Chinese-American Bio Pharmaceutical Society
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 66,420 | 81,260 | −14,840 | 7.1 | — |
| 2012 | 86,138 | 87,220 | −1,082 | 6.4 | — |
| 2013 | 101,001 | 76,605 | 24,396 | 11.1 | — |
| 2014 | 101,927 | 83,783 | 18,144 | 12.8 | — |
| 2015 | 105,187 | 96,600 | 8,587 | 12.2 | — |
| 2016 | 134,189 | 107,721 | 26,468 | 13.9 | — |
| 2017 | 150,381 | 105,202 | 45,179 | 19.3 | — |
| 2018 | 196,370 | 118,881 | 77,489 | 24.9 | — |
| 2019 | 177,057 | 140,101 | 36,956 | 24.3 | — |
| 2020 | 83,890 | 107,296 | −23,406 | 29.1 | — |
| 2021 | 21,080 | 25,502 | −4,422 | 120.5 | — |
| 2022 | 92,810 | 45,314 | 47,496 | 80.4 | — |
| 2023 | 148,904 | 149,773 | −869 | 24.3 | — |
In its most recent public year (2023), this organization spent $869 more than it brought in. Its reserves stood at about 24.3 months of spending, up from 7.1 in 2011.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Chinese-American Bio Pharmaceutical Society's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works